PMID- 13488414
OWN - NLM
STAT- MEDLINE
DCOM- 20000701
LR  - 20191210
IS  - 0570-3107 (Print)
IS  - 0570-3107 (Linking)
VI  - 4
IP  - 11
DP  - 1957 Nov
TI  - A clinical and laboratory evaluation of sulfaethylthidiazole (SETD) in 
      sustained-release dosage forms.
PG  - 729-34
FAU - SABLOSKY, L
AU  - SABLOSKY L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Antibiotic Med Clin Ther (New York)
JT  - Antibiotic medicine & clinical therapy (New York, NY)
JID - 15110190R
RN  - 0 (Delayed-Action Preparations)
RN  - 0 (Sulfathiazoles)
RN  - Y7FKS2XWQH (Sulfathiazole)
SB  - OM
MH  - *Delayed-Action Preparations
MH  - Infections/*therapy
MH  - *Laboratories
MH  - Sulfathiazole
MH  - Sulfathiazoles/analogs & derivatives
OID - CLML: 5833:31427:261:487
OTO - NLM
OT  - *INFECTION/therapy
OT  - *SULFATHIAZOLE/related compounds
EDAT- 1957/11/01 00:00
MHDA- 1957/11/01 00:01
CRDT- 1957/11/01 00:00
PHST- 1957/11/01 00:00 [pubmed]
PHST- 1957/11/01 00:01 [medline]
PHST- 1957/11/01 00:00 [entrez]
PST - ppublish
SO  - Antibiotic Med Clin Ther (New York). 1957 Nov;4(11):729-34.